Hypertension. 2004;43:1-3
Published online before print December 15, 2003, doi: 10.1161/01.HYP.0000110061.06674.ca
Published online before print December 15, 2003, doi: 10.1161/01.HYP.0000110061.06674.ca
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:1.)
© 2004 American Heart Association, Inc.
Editorial Commentary |
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Evidence From New Hypertension Trials
From the Office of the Vice Chancellor (D.W.J.) and Department of Physiology and Biophysics (J.E.H.), University of Mississippi Medical Center, Jackson.
Correspondence to Dr Daniel W. Jones, Vice Chancellor for Health Affairs, Dean, School of Medicine, Herbert G. Langford Professor of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216–4505. E-mail djones@ovc.umsmed.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The recent publication in Hypertension of the complete version of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) provides clinicians and scientists with a valuable resource.1 For the first time, the National Heart, Lung, and Blood Institute (NHLBI)-sponsored National High Blood Pressure Education Program Coordinating Committee presented the national blood pressure guidelines in two forms. The express version, published May 2003, was designed as a succinct guide for the busy primary care clinician.2 The complete version provides the scientific basis, rationale, extensive figures and charts, and references to support the JNC 7 recommendations. The complete version will be of value to specialists, academicians, scientists, and clinicians who seek the evidence that bolsters the report’s recommendations.
There was a 6-year hiatus since JNC 6 was published, which is a much longer interval than that of previous reports. This was partially because of the anticipation of the completion of several important new clinical trials and epidemiology studies. The announcement of the formation of the writing committee for JNC 7 closely followed the publication of results of the NHLBI-sponsored Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) study.3
JNC 7 streamlined the classification of blood pressure and introduced the term "prehypertension," which has received much attention. Prehypertension replaces the older terms of "normal" and "high normal," which suggested complacency and that little action was needed. The term is used to encourage clinicians and patients to take this level of
This article has been cited by other articles:
 |
|
 |
|
  A. Turchin, M. Shubina, E. Breydo, M. L. Pendergrass, and J. S. Einbinder Comparison of Information Content of Structured and Narrative Text Data Sources on the Example of Medication Intensification J. Am. Med. Inform. Assoc., May 1, 2009; 16(3): 362 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jackson Translating the Diabetes Prevention Program Into Practice: A Review of Community Interventions The Diabetes Educator, March 1, 2009; 35(2): 309 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tagami, H. Yamamoto, K. Moriyama, K. Sawai, T. Usui, A. Shimatsu, and M. Naruse A Selective Peroxisome Proliferator-Activated Receptor-{gamma} Modulator, Telmisartan, Binds to the Receptor in a Different Fashion from Thiazolidinediones Endocrinology, February 1, 2009; 150(2): 862 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Gallagher, C. M. Ferrario, and E. A. Tallant Regulation of ACE2 in cardiac myocytes and fibroblasts Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2373 - H2379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Gallagher, C. M. Ferrario, and E. A. Tallant MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1169 - C1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miura, J. Stamler, H. Nakagawa, P. Elliott, H. Ueshima, Q. Chan, I. J. Brown, I. Tzoulaki, S. Saitoh, A. R. Dyer, et al. Relationship of Dietary Linoleic Acid to Blood Pressure: The International Study of Macro-Micronutrients and Blood Pressure Study Hypertension, August 1, 2008; 52(2): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Silvani, D. Grimaldi, S. Vandi, G. Barletta, R. Vetrugno, F. Provini, G. Pierangeli, C. Berteotti, P. Montagna, G. Zoccoli, et al. Sleep-dependent changes in the coupling between heart period and blood pressure in human subjects Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1686 - R1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Turchin, M. Shubina, A. H. Chodos, J. S. Einbinder, and M. L. Pendergrass Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus Circulation, February 5, 2008; 117(5): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sullivan, L. Semprun-Prieto, E. I. Boesen, D. M. Pollock, and J. S. Pollock Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1573 - R1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ueshima, J. Stamler, P. Elliott, Q. Chan, I. J. Brown, M. R. Carnethon, M. L. Daviglus, K. He, A. Moag-Stahlberg, B. L. Rodriguez, et al. Food Omega-3 Fatty Acid Intake of Individuals (Total, Linolenic Acid, Long-Chain) and Their Blood Pressure: INTERMAP Study Hypertension, August 1, 2007; 50(2): 313 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mori, P. M. O'Connor, M. Abe, and A. W. Cowley Jr Enhanced Superoxide Production in Renal Outer Medulla of Dahl Salt-Sensitive Rats Reduces Nitric Oxide Tubular-Vascular Cross-Talk Hypertension, June 1, 2007; 49(6): 1336 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Saavedra The Challenge of Genetic Studies in Hypertension Circ. Res., May 25, 2007; 100(10): 1389 - 1393. [Full Text] [PDF]
|
|
|
|
|
|
T. L. Goodfriend Treating Resistant Hypertension With a Neglected Old Drug Hypertension, April 1, 2007; 49(4): 763 - 764. [Full Text] [PDF]
|
|
|
|
|
|
A. Mahmud and J. Feely Low-Dose Quadruple Antihypertensive Combination: More Efficacious Than Individual Agents-A Preliminary Report Hypertension, February 1, 2007; 49(2): 272 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Soucy, S. Ryoo, A. Benjo, H. K. Lim, G. Gupta, J. S. Sohi, J. Elser, M. A. Aon, D. Nyhan, A. A. Shoukas, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness J Appl Physiol, December 1, 2006; 101(6): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gadonski, B. B. D. LaMarca, E. Sullivan, W. Bennett, D. Chandler, and J. P. Granger Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Interleukin 6 Hypertension, October 1, 2006; 48(4): 711 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Agabiti-Rosei, M. L. Muiesan, and M. Salvetti Evaluation of Subclinical Target Organ Damage for Risk Assessment and Treatment in the Hypertensive Patients: Left Ventricular Hypertrophy J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S104 - S108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamamuro, M. Yoshimura, M. Nakayama, K. Abe, M. Shono, S. Suzuki, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al. Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium Endocrinology, March 1, 2006; 147(3): 1314 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Gallagher, M. C. Chappell, C. M. Ferrario, and E. A. Tallant Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes Am J Physiol Cell Physiol, February 1, 2006; 290(2): C420 - C426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Tallant, C. M. Ferrario, and P. E. Gallagher Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1560 - H1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rizzoni, E. Porteri, C. De Ciuceis, I. Sleiman, L. Rodella, R. Rezzani, S. Paiardi, R. Bianchi, G. Ruggeri, G. E.M. Boari, et al. Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus Hypertension, April 1, 2005; 45(4): 659 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Alfakih, R. A. Lawrance, A. Maqbool, K. Walters, S. G. Ball, A. J. Balmforth, and A. S. Hall The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease Eur. Heart J., March 2, 2005; 26(6): 584 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Morganti Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S70 - S73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Claydon, L. J. Norcliffe, J. P. Moore, M. Rivera, F. Leon-Velarde, O. Appenzeller, and R. Hainsworth Cardiovascular responses to orthostatic stress in healthy altitude dwellers, and altitude residents with chronic mountain sickness Exp Physiol, January 1, 2005; 90(1): 103 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xie, M. Singh, and K. Singh Osteopontin Modulates Myocardial Hypertrophy in Response to Chronic Pressure Overload in Mice Hypertension, December 1, 2004; 44(6): 826 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Bidani and K. A. Griffin Pathophysiology of Hypertensive Renal Damage: Implications for Therapy Hypertension, November 1, 2004; 44(5): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Schlenker, Y. Shi, J. Wipf, D. S. Martin, and C. K. Kost Jr. Fructose feeding and intermittent hypoxia affect ventilatory responsiveness to hypoxia and hypercapnia in rats J Appl Physiol, October 1, 2004; 97(4): 1387 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Perez-Lloret, A. G. Aguirre, D. P. Cardinali, and J. E. Toblli Disruption of Ultradian and Circadian Rhythms of Blood Pressure in Nondipper Hypertensive Patients Hypertension, September 1, 2004; 44(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nickenig Should Angiotensin II Receptor Blockers and Statins Be Combined? Circulation, August 24, 2004; 110(8): 1013 - 1020. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling J. Biol. Chem., July 2, 2004; 279(27): 28670 - 28674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zeng, H. Xu, T.-L. Chew, R. Chisholm, M. M. Sadeghi, Y. S. Kanwar, and F. R. Danesh Simvastatin Modulates Angiotensin II Signaling Pathway by Preventing Rac1-Mediated Upregulation of p27 J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1711 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Gopalakrishnan, D. S. Gardner, S. M. Rhind, M. T. Rae, C. E. Kyle, A. N. Brooks, R. M. Walker, M. M. Ramsay, D. H. Keisler, T. Stephenson, et al. Programming of adult cardiovascular function after early maternal undernutrition in sheep Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R12 - R20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. A. Majid, A. Nishiyama, K. E. Jackson, and A. Castillo Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R27 - R32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sharma Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension? Hypertension, July 1, 2004; 44(1): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Carey Angiotensin Type-1 Receptor Blockade Increases ACE 2 Expression in the Heart Hypertension, May 1, 2004; 43(5): 943 - 944. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF]
|
|